SCHEMBL14879558

SCHEMBL14879558

Cc1cccc(F)c1CNc1ccc(-c2nc(C(F)(F)F)sc2C)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPL P40238 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
APEX1 P27695 2/20 0.35
ALDH1A1 P00352 3/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PTGS2 P35354 2/20 0.34
PTGS1 P23219 1/20 0.34
STIM1 Q13586 3/20 0.34
ORAI1 Q96D31 3/20 0.34
HDAC1 Q13547 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
PKM P14618 1/20 0.33
CD38 P28907 2/20 0.33
FFAR1 O14842 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14879431 0.94 STIM1 (0.38) MPLMEN1KMT2AAPEX1ALDH1A1
SCHEMBL16017352 0.86 ALDH1A1 (0.41) MEN1KMT2AAPEX1ALDH1A1HPGD
SCHEMBL14879654 0.84 MEN1 (0.46) MPLMEN1KMT2AAPEX1ALDH1A1
SCHEMBL14879688 0.84 MPL (0.39) MPLAPEX1ALDH1A1PTGS2PTGS1
SCHEMBL14887602 0.84 STIM1 (0.37) MPLAPEX1ALDH1A1PTGS2PTGS1
SCHEMBL14879755 0.83 PTGS2 (0.42) MEN1KMT2AHPGDPTGS2KDM4E
SCHEMBL16017301 0.80 ALDH1A1 (0.43) MEN1KMT2AAPEX1ALDH1A1HPGD
SCHEMBL14887607 0.77 MEN1 (0.38) MEN1KMT2AAPEX1ALDH1A1SMN1; SMN2
SCHEMBL14887552 0.76 MEN1 (0.54) MEN1KMT2AALDH1A1SMN1; SMN2NPSR1
SCHEMBL14887708 0.74 MEN1 (0.60) MEN1KMT2AALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 US disclosed
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 US disclosed
EP-2768810-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM Calcimedica, Inc. (US) 2014-08-27 EP disclosed
WO-2013059666-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2013-04-25 WO disclosed
WO-2013059666-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2013-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 MPL 2435/4885MEN1 2958/4885KMT2A 4706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.